OCEA Ocean Biomedical, Inc. Net Sales Margin

Corporate emblem and logo of Ocean Biomedical Inc (OCEA)

Ocean Biomedical, Inc. (OCEA) operates within the commercialization of university patents, where market access is restricted by FDA requirements. Aggregate net margin helps track the dynamics of this process, with 0.00 serving as the current metric level. The business relies on grants for the development of anti-malarial vaccines and oncology drugs. Preclinical research remains independent of GDP cycles, demonstrating high resilience to macroeconomic fluctuations.

Ocean Biomedical, Inc. (OCEA) - Net Sales Margin from 04/28/2023 to 05/24/2025

Ocean Bio (OCEA) - metric breakdowns and financial figures

- share price and expert price forecast:
Fundamental valuation:Ocean Biomedical Inc - OCEA
Finished products of Ocean Biomedical Inc

For Ocean Biomedical, Inc. (OCEA), the aggregate net profit margin reflects the dependence of earnings on the success of oncology and malaria research. This indicator is calculated as the ratio of net income to total revenue, measuring the efficiency of converting revenue into final capital. The trend of this metric captures the business's reaction to market signals and licensing deals. Negative values underscore the need for external financing to cover operating expenses. Steady growth of this metric would confirm the fundamental stability of the business model.

Competitors of Ocean Biomedical, Inc. (OCEA)

argenx (ARGX) - Net Margin|BNTX - Company Sales Margin|ABVX (Abivax Pharma) - Net Sales Margin|Return on Sales by Net Profit ADMA Bio (ADMA)|Return on Sales by Net Profit PTGX (Protagonist Therapeutics Inc)|Net Sales Margin immunovant.com (IMVT)|Net Margin kiniksa.com KNSA|Grifols SA (GRFS) - Net Margin|Adaptive Biotechnologies Inc. - Net Sales Margin|Net Margin Celldex Therapeutics|AUPH: Net Sales Margin|BCRX - Company Sales Margin|VERA (Vera Corp) - Net Sales Margin|Dianthus Pharma (DNTH) - Company Sales Margin|Net Margin Pharvaris Pharma (PHVS)|Net Sales Margin AbCellera Corp (ABCL)|Net Sales Margin TRML (Tourmaline Bio Inc)|Company Sales Margin precigen.com (PGEN)|PHAR - Net Margin|Net Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Sales by Net Profit|Zenas Corp (ZBIO) - Net Sales Margin|Return on Sales by Net Profit IMNM|GOSS: Net Profit Rate|Net Margin KalVista Pharma (KALV)|SEPN - Net Margin|Net Sales Margin PVLA (pieris.com)|Net Sales Margin Savara Pharma SVRA|RIGL: Return on Sales by Net Profit|ANAB - Net Sales Margin|ATXS: Net Sales Margin|ENGN - Company Sales Margin|Return on Sales by Net Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Company Net Profitability|Net Sales Margin ACRS|Return on Sales by Net Profit kyvernatx.com KYTX|Net Sales Margin TLSA (Tiziana Life Sciences, Ltd.)|Net Sales Margin Cabaletta Bio CABA|VTYX: Return on Sales by Net Profit|Theratechnologies Inc. (THTX) - Return on Sales by Net Profit|AVTX: Net Sales Margin|ELDN - Company Sales Margin|AGEN (Agenus, Inc) - Net Sales Margin|Net Sales Margin Climb Bio, Inc.|Net Margin Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Net Profit Rate|Net Sales Margin ADAG (Adagene Inc)|IMA - Return on Sales by Net Profit|STTK - Net Margin|EQ (equilliumbio.com) - Net Return on Sales|CNTB: Net Sales Margin|Immunic Inc (IMUX) - Net Sales Margin|ATRA (Atara Biotherapeutics Inc) - Net Sales Margin|Net Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Net Profit Rate|Adicet Bio, Inc. - Net Return on Sales|Celularity Inc - Return on Sales by Net Profit|Net Sales Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Net Sales Margin|Kezar Life Sciences, Inc. (KZR) - Return on Sales by Net Profit|SAB Biotherapeutics Inc. (SABS) - Net Margin|Return on Sales by Net Profit Akari Therapeutics plc|Net Margin enlivex.com|q32bio.com (QTTB) - Company Sales Margin|Net Sales Margin GOVX|Edesa Biotech, Inc. - Net Return on Sales|iBio Inc - Return on Sales by Net Profit|Net Sales Margin Carisma Therapeutics CARM|XTLB - Net Margin|BOLT (boltbio.com) - Net Return on Sales|HCWB: Net Sales Margin|Aptevo (APVO) - Net Sales Margin|Net Margin AIM ImmunoTech|Return on Sales by Net Profit Aditxt (ADTX)|Return on Sales by Net Profit GRI (GRI Bio Corporation)|XORTX - Net Return on Sales|Net Sales Margin HIND (Vyome Holdings Inc.)|Net Profit Rate REVB|Indaptus - Net Sales Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Net Return on Sales|CALI: Net Sales Margin|Affimed NV - Net Profit Rate|Net Margin Allakos Inc.|Net Sales Margin HOOKIPA Pharma|Net Margin IGM Biosciences, Inc. (IGMS)|ITOS - Net Margin|Net Sales Margin TCBP (TC BioPharm (Holdings) PLC)|THRD - Return on Sales by Net Profit